AACR Congratulates Jim Allison on Nobel Prize
On Monday, James P. Allison, PhD, a Fellow of the AACR Academy and a past member of the AACR’s...
Tag: immunotherapy
On Monday, James P. Allison, PhD, a Fellow of the AACR Academy and a past member of the AACR’s...
As a monthly feature on this blog, we spotlight the 10 articles selected by our editors from each journal...
In the midst of the dog days of summer, the U.S. Food and Drug Administration (FDA) has provided good...
Treatment with checkpoint inhibitors is often billed as gentler than chemotherapy—and it is true that immunotherapy doesn’t come with...
During the early part of summer 2018, the U.S. Food and Drug Administration (FDA) has approved several new anticancer...
This week marks the fourth anniversary of Cancer Research Catalyst, the official blog of the American Association for Cancer...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which pembrolizumab...
A study presented at the AACR Annual Meeting 2018 discussed preliminary data on an off-the-shelf, T-cell receptor (TCR)-less, dual-targeted...
Early this week, the U.S. Food and Drug Administration (FDA) approved a combination immunotherapy regimen for treating certain patients...
An exciting area in drug development, immunotherapy is being increasingly utilized by patients with different cancer types. These treatments...